MK Bhutani
MK Bhutani publishes mostly in Economics and Econometrics, Pulmonary and Respiratory Medicine and Oncology, on topics such as Health Systems, Economic Evaluations, Quality of Life, Lung Cancer Treatments and Mutations and Economic and Financial Impacts of Cancer.
- World rank
- #3,264,088 of 7,710,434 ranked researchers
- Rank in India
- #69,827 of 280,097
- Works
- 32
- Citations
- 710
- Citations per work
- 22.2
What does MK Bhutani research?
MK Bhutani's work is mostly in Medicine (30%), Economics, Econometrics and Finance (13%), Health Professions (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1751.9%
- Health Sciences1134.8%
- Medicine1030.0%
- Health Professions24.8%
- Social Sciences413.3%
- 1Economics and Econometrics13% of their works
- 2Pulmonary and Respiratory Medicine11% of their works
- 3Oncology8% of their works
- 4Surgery7% of their works
- 5General Health Professions5% of their works
- 6Cardiology and Cardiovascular Medicine4% of their works
Research topics
- Health Systems, Economic Evaluations, Quality of Life
- Lung Cancer Treatments and Mutations
- Economic and Financial Impacts of Cancer
- Cancer, Lipids, and Metabolism
- Curcumin's Biomedical Applications
- Piperaceae Chemical and Biological Studies
- Primary Care and Health Outcomes
- Medicinal Plants and Neuroprotection
Which keywords describe MK Bhutani's research?
The keywords of their largest research topics: Clinical Trials, Cost-effectiveness Analysis, Neuroprotective, Quality of Life, EGFR Mutations, Targeted Therapy, Antioxidant and Bioavailability.
- Quality Improvement
- Piperine
- Lipid Metabolism
- Curcumin
- Bacopa monnieri
- Cost of Care
- Bioavailability
- Targeted Therapy
- Quality of Life
- Cost-effectiveness Analysis
- Clinical Trials
- Neuroprotective
- EGFR Mutations
- Antioxidant
- Cancer
- Financial Toxicity
- Centella asiatica
- Fatty Acid Synthase
- Pharmacology
- Primary Care
- Therapeutic
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Clinical Trials72 topics
- Cost-effectiveness Analysis61 topic
- Neuroprotective63 topics
- Quality of Life61 topic
- EGFR Mutations51 topic
- Targeted Therapy51 topic
- Antioxidant42 topics
- Bioavailability42 topics
- Cancer42 topics
- Cost of Care31 topic
- Financial Toxicity31 topic
- Bacopa monnieri21 topic
- Centella asiatica21 topic
- Curcumin21 topic
- Fatty Acid Synthase21 topic
- Lipid Metabolism21 topic
- Pharmacology21 topic
- Piperine21 topic
- Primary Care21 topic
- Quality Improvement21 topic
- Therapeutic21 topic
Where does MK Bhutani work?
MK Bhutani's main affiliation in the publication record is Tata Consultancy Services (India), India.
How many publications and citations does MK Bhutani have?
OpenAlex counts 32 works and 710 citations for MK Bhutani, an h-index of 6, ranking #3,264,088 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about MK Bhutani. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.